Table 1 Comparison of the patients’ demographic and clinical characteristics treated by the three different strategies (n = 51)
Items | Mifepristone + misoprostol | Mifepristone + Rivanol | Hysterotomy | p |
|---|---|---|---|---|
|  | (n = 16) | (n = 14) | (n = 21) |  |
Age(y) | Â | Â | Â | 0.142 |
 ≤ 30 | 9(56.3) | 9(64.3) | 6(28.6) |  |
31–40 | 7(43.7) | 5(35.7) | 13(61.9) |  |
 > 40 | 0 | 0 | 2(9.5) |  |
Gestational weeks(w) | Â | Â | Â | 0.000 |
13–16 | 16(100.0) | 3(21.4) | 4(19.1) |  |
17–20 | 0 | 8(57.2) | 12(57.1) | |
21–23 | 0 | 3(21.4) | 5(23.8) | |
Gravidity(n) | Â | Â | Â | 0.579 |
 ≤ 3 | 5(31.3) | 3(21.4) | 10(47.6) |  |
4–5 | 4(25.0) | 4(28.6) | 3(14.3) |  |
 > 6 | 7(43.7) | 7(50.0) | 8(38.1) |  |
Parity(n) | Â | Â | Â | 0.148 |
1 | 9(56.3) | 10(71.4) | 8(38.1) | Â |
2 | 7(43.7) | 4(28.6) | 13(61.9) | Â |
Cesarean sections(n) | Â | Â | Â | 0.421 |
1 | 10(62.5) | 10(71.4) | 10(47.6) | Â |
2 | 6(37.5) | 4(28.6) | 11(52.4) | Â |
Years since the last cesarean sections(y) | Â | Â | Â | 0.325 |
 ≤ 2 | 5(31.3) | 4(28.6) | 2(9.5) |  |
3–5 | 8(50.0) | 8(57.1) | 11(52.4) | |
 > 5 | 3(18.7) | 2(14.3) | 8(38.1) |  |
Symptoms | Â | Â | Â | 0.982 |
None | 11(55.0) | 10(62.5) | 13(48.1) | Â |
Vaginal bleeding | 4(20.0) | 2(12.5) | 6(22.2) | Â |
Abdominal pain | 3(15.0) | 3(18.7) | 5(18.5) | Â |
Both | 2(10.0) | 1(6.3) | 3(11.1) | Â |
Thinnest thickness of lower uterus(mm) | Â | Â | Â | 0.063 |
 ≤ 0.5 | 4(25.0) | 4(28.6) | 9(42.9) |  |
0.5–3 | 4(25.0) | 1(7.1) | 8(38.1) | |
 > 3 | 8(50.0) | 9(64.3) | 4(19.0) | |
Type of placenta previa status | Â | Â | Â | 0.013 |
Marginal type | 5(31.3) | 4(28.6) | 3 (14.3) | Â |
Partial type | 5(31.3)* | 1 (7.1) | 0(0)* | Â |
Complete type | 6(37.5)* | 9 (64.3) | 18(85.7)* | Â |
Type of PAS | Â | Â | Â | 0.403 |
Placenta Adherenta/creta | 7(43.8) | 7(50.0) | 6(28.6) | Â |
Placenta increta | 9(56.3) | 7(50.0) | 15(71.4) |